BioCentury
ARTICLE | Clinical News

Xiaflex: Phase IIb started

February 22, 2016 8:00 AM UTC

Endo began a placebo-controlled, U.S. Phase IIb trial to evaluate 0.84 mg collagenase clostridium histolyticum per session for up to 3 sessions about 21 days apart in about 350 women ages >=18. Patients will receive 12 injections administered during each session into cellulite dimples in the left or right buttock or left or right posterior thigh. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article